Provided by Tiger Trade Technology Pte. Ltd.

Citius Pharmaceuticals, Inc.

0.5754
-0.0248-4.13%
Post-market: 0.57540.00000.00%18:53 EDT
Volume:377.77K
Turnover:219.92K
Market Cap:15.80M
PE:-0.27
High:0.6100
Open:0.6100
Low:0.5700
Close:0.6002
52wk High:2.19
52wk Low:0.4687
Shares:27.45M
Float Shares:26.96M
Volume Ratio:0.32
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1219
EPS(LYR):-3.3830
ROE:-81.09%
ROA:-26.57%
PB:0.24
PE(LYR):-0.17

Loading ...

Citius Pharmaceuticals files to sell 5.43M shares of common stock for holders

TIPRANKS
·
May 23

Citius Oncology files draft information statement on warrant, loan conversion share issuance

Reuters
·
May 20

U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology

Reuters
·
May 19

Citius Pharmaceuticals Coverage Assumed by HC Wainwright & Co. at Buy

Dow Jones
·
May 18

Citius Pharmaceuticals assumed with a Buy at H.C. Wainwright

TIPRANKS
·
May 18

Citius Oncology Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 16

Citius Pharmaceuticals Q2 revenue rises on LYMPHIR launch

Reuters
·
May 16

Citius Oncology FY26 Q2 net loss widens to $26.6 million; revenue rises to $1.7 million

Reuters
·
May 16

Citius Pharmaceuticals Q2 Net Income USD -21.2 Million

THOMSON REUTERS
·
May 16

Press Release: Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 16

Citius Oncology Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
May 09

Citius Pharma adds $0.9 share conversion option to $3.8 million Citius Oncology note

Reuters
·
May 09

Citius Oncology issues new warrants for 25555556 shares after USD 11.5 million exercise

Reuters
·
May 06

Citius Oncology enters up to $25 million senior secured loan facility with Avenue Capital Group

Reuters
·
May 06

Citius Oncology announces initial shipment of LYMPHIR to Europe

TIPRANKS
·
Apr 29

Citius Oncology ships first international LYMPHIR order to Europe via named patient programs

Reuters
·
Apr 29

Citius Pharma prices USD 5 million registered direct offering at USD 0.99/share

Reuters
·
Apr 24

Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Apr 24

Citius Pharmaceuticals shareholders elected seven directors at annual meeting

Reuters
·
Apr 07

Citius Oncology cites early LYMPHIR uptake as 83% of target accounts advance formulary review

Reuters
·
Apr 01